Study Status: Withdrawn
Recruit Status: Withdrawn
Study Type: Interventional
Official Title: Low-doses Alemtuzumab and Rituximab Combination as First Line Treatment in Aplastic Anemia
Brief Summary: The purpose of the study is to evaluate the efficacy of combination of alemtuzumab and rituximab as first line therapy in aplastic anemia.